The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause. Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause. Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Wednesday, August 22, 2012

The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause.

http://www.ncbi.nlm.nih.gov/m/pubmed/21892704/

Sent from my iPhone

0 comments :

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments ( Atom )